DayFR Euro

Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reports

Market Closed –


Nyse

22:00:02 04/10/2024

Varies. 5j.

Varia. Jan 1

28,58 USD

+0,85 %

-1,75 %

-0,73 %

October 7, 2024 at 02:13

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the U.S. pharmaceutical giant to make changes to turn around its performance, the Wall Street Journal reported Sunday.

Go to the original article.

Legal notice

Legal notice

Contact us for any correction request

© Reuters – 2024

Activist investor Starboard Value takes $1 billion stake in Pfizer, WSJ reports

02:13

RE

PFIZER, INC. : BMO Capital for purchase

04/10

ZM

PFIZER, INC. : BMO Capital optimistic about the file

04/10

ZM

Haleon buys £230m worth of shares from Pfizer

03/10

AN

Haleon completes £230m buyback of Pfizer shares

03/10

MT

UK stocks recover as manufacturing sector continues to expand

01/10

MT

Pfizer: Boeing, Nio, XPeng… the stocks to follow today on Wall Street

01/10

TO THE

Pfizer sells $3.2 billion in Haleon shares

01/10

TO THE

Stocks mostly green following improvement in UK manufacturing

01/10

AN

Haleon plc (LSE:HLN) announces a share buyback for 455,701,825 shares, representing 4.99% of its issued share capital.

01/10

CI

Haleon: 60.5 million shares repurchased from Pfizer

01/10

CF

Pfizer sells 701 million shares of Haleon for $3.57 billion

01/10

MT

Pfizer cuts stake in Haleon to 15% with £2.7bn sale

01/10

AN

Pfizer sells more than 3 billion euros of shares in British Haleon

01/10

AW

The FTSE 100 in the green, but other stocks fall before the PMIs

01/10

AN

Stocks open in the green after UK store price data

01/10

AN

Wall Street stays away from Chinese madness and European spleen

01/10

Direct from the markets: LVMH, Renault, Unibail, Stellantis, Covestro, Haleon, PepsiCo, CVS…

01/10

Haleon to buy £230m worth of shares from Pfizer

01/10

MT

Pfizer sells $3.3 billion stake in Sensodyne maker Haleon

01/10

RE

Pfizer plans to raise around £2.7 billion from sale of Haleon stake

30/09

AN

Pfizer increases Haleon offer to 640 million shares from 540 million shares previously

30/09

MT

Sector Update: Healthcare Stocks Mixed in Afternoon

30/09

MT

Pfizer plans to sell about 540 million shares of Haleon

30/09

MT

Pfizer to sell about 5.9% stake in British company Haleon, stockbroker says

30/09

RE

Pfizer, Inc. is the world’s leading pharmaceutical group. Turnover by product family is broken down as follows: – primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, products based on mRNA, etc. ; – specialized care products (13.8%): drugs used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory drugs, etc. ; – products used in oncology (12.1%); – others (1.3%). At the end of 2022, the group has more than 35 production sites around the world. The geographical distribution of turnover is as follows: United States (42.3%), Europe (21.9%) and others (35.8%).

More information about the company

Sale

Purchase

Average recommendation

ACCUMULATE

Last Closing Course

28,58USD

Average course objective

33,56USD

/ Average Objective

+17,44 %

Consensus

OUR EXPERTS AT YOUR LISTENANCE

Monday – Friday 9 a.m. – 12 p.m. / 2 p.m. – 6 p.m.

-

Related News :